Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
SK bioscience Secures Additional PAHO Contract to Supply Varicella Vaccines to Latin America
Friday, February 28, 2025SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure today announced that the company had received prior notification from the Pan American Health Organization PAHO
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
Friday, February 28, 2025Alphamab Oncology and CSPC Pharmaceutical Group Co Ltd jointly announced that the first patient has been successfully dosed in the Phase III clinical study Study ID JSKN of antiHER biparatopic antibodydrug conjugate ADC JSKN
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
Friday, February 28, 2025WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO today announced that it has again passed the GMP inspection by Japans Pharmaceuticals and Medical Devices Agency PMDA for its drug substance facilities...
A Southern Hemisphere First – New Cutting-Edge Radiotherapy now available at Icon Cancer Centre
Friday, February 28, 2025Icons decision to embrace RapidArc Dynamic was driven by strong early results showing faster treatment planning reduced radiation exposure to healthy organs and potential to set new standards in patientcentred care
Nxera Pharma Assigns Japan and APAC (ex- China) Rights to Cenerimod for Autoimmune Diseases to Viatris
Friday, February 28, 2025Nxera Pharmahas entered an assignment agreement with Viatris Inc Viatris a global healthcare company and Idorsia Pharmaceuticals Ltd Idorsia regarding the development and commercialization of cenerimod a clinical stage immunology
Agilisium Signs MoU with IITM Pravartak to Accelerate Life Sciences and Healthcare Research
Thursday, February 27, 2025Agilisium a leading data innovation partner for Life Sciences companies entered into a strategic partnership with IITM Pravartak to accelerate Life Sciences and Healthcare endeavors With this move the company aims to collaborate on joint research
Swissmedic Approves CSL Behring’s ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)
Thursday, February 27, 2025Global biotechnology leader CSLannounced today that the Swiss Agency for Therapeutic Products Swissmedic has granted marketing authorization to ANDEMBRY garadacimab for longterm prophylaxis of recurring attacks of hereditary angioedema
RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties
Thursday, February 27, 2025RedHill Biopharma Ltd a specialty biopharmaceutical company today announced that it has entered into an exclusive worldwide development and commercialization licensing agreement excluding North America the Agreement with Hyloris Pharmaceuticals SA Eu...
AstraZeneca’s Camizestrant Improves Progression-Free Survival in First-Line Advanced HR-Positive Breast Cancer
Thursday, February 27, 2025Positive highlevel results from a planned interim analysis of the SERENA Phase III trial showed that AstraZenecas camizestrant in combination with a cyclindependent kinase CDK inhibitor palbociclib ribociclib or abemaciclib
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma
Wednesday, February 26, 2025Kangpu Biopharmaceuticals Ltd Kangpu today announced that the Company has received IND approval from the CDE Center for Drug Evaluation of China National Medical Products Administration NMPA for KPG for the treatment of relapsedrefractory multiple my...
